Official Title
Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease in Hospitalized Patients
Brief Summary

Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical ventilation)during hospitalization. Some risk factors are already known but better targeting of suchpatients is still needed, at least because existing risk factors are not strong enough toprovide an accurate prediction. Care organization would benefit for such a predictivetool.Oropharyngeal and gut microbiota could potentially fill a significant gap in predictiveperformances. The investigators therefore propose to sample 200 patients (oropharyngealand rectal swab) admitted in infectious disease department at Bichat Hospital and at highrisk of needing intensive care during hospitalization. The investigators plan to performmetagenomic sequencing and bioinformatic analysis of these samples to characterize thediversity of bacterial species present in the oropharynx and the gut and to identify newfactors associated with the need for intensive care. Aside metagenomic analyses, Theinvestigators will perform semi-quantitative cultures of the oropharyngeal and gutmicrobiota to identify and quantify pathogens in order to predict the risk of bacterialinfections in COVD-19 patients.For patients transferred in intensive care unit, The investigators will to performanother series of samples to better characterize the evolution of microbiota duringmechanical ventilation and identify factors associated with the risk of developing aventilator-associated pneumonia.Microbiota data will be considered together with the host genotype, the viral sequenceand a deep immunological profiling to identify the main determinants of the evolutiontoward severity of COVID-19.

Detailed Description

Patients hospitalized for COVID-19 may need intensive care (e.g. mechanical ventilation)
during hospitalization. Some risk factors are already known (e.g. sex, comorbidities,
initial clinical presentation inflammatory cytokines), but better targeting of such
patients is still needed, at least because existing risk factors are not strong enough to
provide an accurate prediction. Care organization would benefit for such a predictive
tool.

Oropharyngeal and gut microbiota could fill a significant gap in predictive performances.
The investigators therefore propose to take advantage of the French-COVID cohort and
sample 200 patients (oropharyngeal and rectal swab) admitted in infectious disease
department at Bichat Hospital and at high risk of needing intensive care during
hospitalization. The investigators plan to perform metagenomic sequencing and
bioinformatic analysis of these samples to characterize the diversity of bacterial
species present in the oropharynx and the gut and to identify new factors associated with
the need for intensive care. Aside metagenomic analyses, The investigators will perform
semi-quantitative cultures of the oropharyngeal and gut microbiota to identify and
quantify pathogens in order to predict the risk of bacterial infections in COVD-19
patients.

The genetic determinants of the host (the patient) could also be predictive of the
severity of the disease and so does the immunological response to the COVID-19. Likewise,
it has been suggested that certain mutations (notably the D614G mutation) of the viral
sequence could be associated with the infectivity of the virus.

In addition to the direct role of the microbiota in the course of infection, the immune
characteristics specific to the host, by themselves or in interaction with the
microbiota, could play an important role in the progression of the disease.

This project focuses on the clinical characterization of COVID-19 and its evolution, as
well as disease management.

The research focuses on 4 main areas:

- Characterization of the oropharyngeal and intestinal microbiota of patients with
COVID-19

- Characteristics of the host (genotype)

- Immune characteristics of the host

- Characteristics of the SARS-CoV-2 viral genome

For patients transferred in intensive care unit, The investigators will to perform
another series of samples to better characterize the evolution of microbiota during
mechanical ventilation and identify factors associated with the risk of developing a
ventilator-associated pneumonia.

Unknown status
COVID19

Other: oropharyngeal and intestinal microbiota

analysis of oropharyngeal and intestinal microbiota

Other: host genotype

analysis of a part of host genotype

Other: host immune factors

analysis of host immune factors

Other: viral sequence

analysis of viral sequence

Eligibility Criteria

Inclusion Criteria:

- Adult patient with documented SARS-CoV-2 infection requiring hospitalization.

Exclusion Criteria:

- Lack of consent

- Patients hospitalized in an intensive care unit

- Patient under guardianship or curatorship

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

LESCURE
Paris, France

Investigator: xavier lescure
xavier.lescure@aphp.fr

Contacts

Etienne Ruppé
1 40 25 80 00 - 33
etienne.ruppe@aphp.fr

Xavier Lescure
1 40 25 80 00 - 33
xavier.lescure@aphp.fr

Not Provided

Assistance Publique - Hôpitaux de Paris
NCT Number
MeSH Terms
COVID-19
Immunologic Factors